FL
BMY icon

Fort LP’s Bristol-Myers Squibb BMY Stock Holding History

Fort LP’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$268K Buy
5,177
+177
+4% +$8.3K 0.68% 68
2024
Q2 		$208K Buy
5,000
+792
+19% +$35.4K 0.53% 134
2024
Q1 		$228K Sell
4,208
-127
-3% -$6.47K 0.57% 113
2023
Q4 		$222K Buy
4,335
+150
+4% +$7.87K 0.55% 122
2023
Q3 		$243K Buy
4,185
+174
+4% +$10.7K 0.67% 86
2023
Q2 		$257K Sell
4,011
-98
-2% -$6.57K 0.68% 85
2023
Q1 		$285K Sell
4,109
-1,657
-29% -$117K 0.74% 69
2022
Q4 		$415K Sell
5,766
-2,160
-27% -$163K 0.63% 66
2022
Q3 		$563K Sell
7,926
-5,481
-41% -$398K 0.7% 10
2022
Q2 		$1.03M Sell
13,407
-9,028
-40% -$688K 0.7% 4
2022
Q1 		$1.64M Sell
22,435
-1,469
-6% -$98.6K 0.62% 15
2021
Q4 		$1.49M Buy
23,904
+363
+2% +$21.3K 0.48% 85
2021
Q3 		$1.39M Sell
23,541
-2,189
-9% -$144K 0.46% 101
2021
Q2 		$1.72M Sell
25,730
-1,432
-5% -$93.4K 0.5% 80
2021
Q1 		$1.72M Buy
27,162
+1,317
+5% +$81.9K 0.48% 100
2020
Q4 		$1.6M Buy
25,845
+5,785
+29% +$356K 0.48% 107
2020
Q3 		$1.21M Buy
20,060
+1,736
+9% +$104K 0.51% 65
2020
Q2 		$1.08M Sell
18,324
-29,344
-62% -$1.76M 0.58% 31
2020
Q1 		$2.66M Sell
47,668
-4,937
-9% -$302K 0.6% 18
2019
Q4 		$3.38M Buy
52,605
+30,740
+141% +$1.76M 0.6% 4
2019
Q3 		$1.11M Buy
21,865
+15,156
+226% +$712K 0.21% 205
2019
Q2 		$304K Buy
6,709
+5,713
+574% +$266K 0.06% 269
2019
Q1 		$48K Buy
996
+409
+70% +$20.4K 0.01% 367
2018
Q4 		$31K Buy
587
+51
+10% +$2.74K 0.01% 367
2018
Q3 		$33K Buy
+536
New +$31.8K 0.01% 360

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fort LP's BMY Position: Q3 2024 in Review

Fort LP increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q3 2024, buying an estimated $8.3K and bringing the position to 5,177 shares worth $268K. The position accounts for 0.68% of the portfolio, ranked #68.

Fort LP first reported a position in BMY in Q3 2018 and has held it in 25 quarters since. The position peaked at $3.38M in Q4 2019. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Fort LP held 5,177 shares of Bristol-Myers Squibb worth $268K as of Q3 2024.
  • Fort LP bought 177 Bristol-Myers Squibb shares in Q3 2024, an estimated $8.3K.
  • Bristol-Myers Squibb made up 0.68% of Fort LP's portfolio in Q3 2024, its #68 holding.
  • Fort LP first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 25 quarters since.
  • Fort LP's Bristol-Myers Squibb position peaked at $3.38M in Q4 2019.
  • 2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Fort LP's 13F filing for Q3 2024, filed 29 Oct 2024.